SCHEMBL2240288

SCHEMBL2240288

COc1cccc2c1[C@@H](N)CO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.44
CYP19A1 P11511 1/20 0.42
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
HTR1B P28222 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1D P25100 4/20 0.39
ADRA1A P35348 4/20 0.39
ADRA1B P35368 4/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1922464 1.00 HTR1A (0.44) HTR1ACYP19A1DRD2DRD1HTR1B
SCHEMBL19829900 0.83 MAP3K14 (0.45) HTR1ADRD2HTR2AADRA1A
SCHEMBL3412427 0.83 NPC1 (0.43) HTR1ADRD2DRD1HTR1BHTR2A
SCHEMBL3408454 0.83 ADRA1D (0.38) HTR1AHTR2CADRA1DADRA1AADRA1B
SCHEMBL3581276 0.74 ALDH1A1 (0.35) DRD2HTR2AHTR2CADRA1AALDH1A1
SCHEMBL9787362 0.74 CYP3A4 (0.40) HTR1ACYP19A1DRD2DRD1HTR1B
SCHEMBL21262962 0.74 CYP19A1 (0.45) HTR1ACYP19A1ADRA1DADRA1AADRA1B
SCHEMBL20480264 0.74 CYP19A1 (0.45) HTR1ACYP19A1ADRA1DADRA1AADRA1B
SCHEMBL9620283 0.74 CYP3A4 (0.40) HTR1ACYP19A1DRD2DRD1HTR1B
SCHEMBL9787063 0.74 CYP3A4 (0.40) HTR1ACYP19A1DRD2DRD1HTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994324-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2011-08-09 US disclosed
EP-2262773-A1 2-AMINOQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
WO-2009109491-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227584-A1 2-AMINOQUINOLINE DERIVATIVES HTR5A, HTR2C, HTR2B HTR1A 8/4885CYP19A1 1966/4885DRD2 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.